Literature DB >> 23620693

Granulocyte colony-stimulating factor does not enhance recruitment of bone marrow-derived cells in rats with acute myocardial infarction.

Daisuke Sato1, Hajime Otani, Masanori Fujita, Takayuki Shimazu, Kei Yoshioka, Chiharu Enoki, Naoki Minato, Toshiji Iwasaka.   

Abstract

Despite the potential benefit of granulocyte colony-stimulating factor (G-CSF) therapy in patients with acute myocardial infarction (MI), the efficacy of G-CSF in regenerating the heart after MI remains controversial. The authors hypothesize that the limited efficacy of G-CSF is related to its inhibitory effect on recruitment of bone marrow-derived cells (BMCs) to the infarcted tissue. MI was induced in rats with intrabone marrow-bone marrow transplantation from syngenic rats expressing green fluorescence protein to track BMCs. G-CSF was administered for five days after the onset of MI. G-CSF increased the number of CD45(+) cells in the peripheral circulation but did not increase their recruitment to the heart. G-CSF had no effect on myocardial stromal-derived factor-1 alpha and chemokine (C-X-C motif) receptor 4 (CXCR4) expression in mononuclear cells in the peripheral blood and CXCR4(+) cells in the heart. G-CSF had no effect on angiogenesis, myocardial fibrosis or left ventricular function four weeks after MI. These results suggest that G-CSF mobilizes BMCs to the peripheral circulation but does not increase recruitment to the infarcted myocardium despite preservation of the stromal-derived factor-1 alpha/CXCR4 axis.

Entities:  

Keywords:  Bone marrow cells; CXCR4; G-CSF; Myocardial infarction; SDF-1α

Year:  2012        PMID: 23620693      PMCID: PMC3628418     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  44 in total

1.  Phenotypic modulation and turnover of bone marrow-derived cells after myocardial infarction in rats.

Authors:  Daisuke Sato; Hajime Otani; Chiharu Enoki; Masanori Fujita; Naoki Minato; Toshiji Iwasaka
Journal:  Cardiovasc Pathol       Date:  2010-05-26       Impact factor: 2.185

2.  Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.

Authors:  Antonio Maria Leone; Sergio Rutella; Giuseppina Bonanno; Anna Maria Contemi; Daniela G de Ritis; Maria Benedetta Giannico; Antonio G Rebuzzi; Giuseppe Leone; Filippo Crea
Journal:  Int J Cardiol       Date:  2005-07-26       Impact factor: 4.164

3.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Dietlind Zohlnhöfer; Ilka Ott; Julinda Mehilli; Kathrin Schömig; Fabian Michalk; Tareq Ibrahim; Günther Meisetschläger; Jasper von Wedel; Hildegard Bollwein; Melchior Seyfarth; Josef Dirschinger; Claus Schmitt; Markus Schwaiger; Adnan Kastrati; Albert Schömig
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

4.  Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.

Authors:  Yasuo Sugano; Toshihisa Anzai; Tsutomu Yoshikawa; Yuichiro Maekawa; Takashi Kohno; Keitaro Mahara; Kotaro Naito; Satoshi Ogawa
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

5.  G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.

Authors:  Stefan Brunner; Bruno C Huber; Rebekka Fischer; Michael Groebner; Marcus Hacker; Robert David; Marc-Michael Zaruba; Marcus Vallaster; Christoph Rischpler; Andrea Wilke; Armin Gerbitz; Wolfgang-Michael Franz
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

6.  G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells.

Authors:  Hyun Kyung Kim; Maria De La Luz Sierra; Cassin Kimmel Williams; A Virginia Gulino; Giovanna Tosato
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

Review 7.  G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction--a relevant treatment?

Authors:  Rasmus Sejersten Ripa; Jens Kastrup
Journal:  Exp Hematol       Date:  2008-03-20       Impact factor: 3.084

8.  Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Guilherme V Silva; Claudio T Mesquita; Luciano Belém; William K Vaughn; Fernando O D Rangel; Joao A R Assad; Antonio C Carvalho; Rodrigo V C Branco; Maria I D Rossi; Hans J F Dohmann; James T Willerson
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

9.  Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.

Authors:  Hajime Morimoto; Masafumi Takahashi; Yuji Shiba; Atsushi Izawa; Hirohiko Ise; Minoru Hongo; Kiyohiko Hatake; Kazuo Motoyoshi; Uichi Ikeda
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

10.  Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation.

Authors:  Kimiko Tatsumi; Hajime Otani; Daisuke Sato; Chiharu Enoki; Toshiji Iwasaka; Hiroji Imamura; Shoichiro Taniuchi; Kazunari Kaneko; Yasushi Adachi; Susumu Ikehara
Journal:  Circ J       Date:  2008-08       Impact factor: 2.993

View more
  2 in total

1.  Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet.

Authors:  Jamie R Karcher; Andrew S Greene
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-20       Impact factor: 4.249

2.  Choroidal thickness and granulocyte colony-stimulating factor in tears improve the prediction model for coronary artery disease.

Authors:  José Lorenzo Romero-Trevejo; Lourdes Fernández-Romero; Josué Delgado; Erika Muñoz-García; Andrés Sánchez-Pérez; Mora Murri; Mario Gutiérrez-Bedmar; Manuel Francisco Jiménez-Navarro
Journal:  Cardiovasc Diabetol       Date:  2022-06-09       Impact factor: 8.949

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.